Protocol Development
The Office for Clinical Research is committed to supporting Cancer Center clinical investigators in the development and implementation of investigator-initiated clinical trials. The OCR assists investigators at any stage in their trials by offering specialized assistance in the following:
- Development and writing of clinical trial protocols in compliance with regulatory authorities
- Assistance with submissions to PRC and IRB-HSR
- Preparation of additional documentation (i.e. FDA submissions, Informed Consents and Investigators Brochures)
- Educate study staff to assist study start-up
- Individualized support
To discuss your investigator-initiated trial needs, please contact our Protocol Development Specialist.
|
Amy R. Lankford, PhD |
Additional Resources:
